(Boursier.com) — Zimmer Biomet, the American supplier of medical equipment, published for its fourth fiscal quarter revenues of 1.825 billion dollars, an increase of 3% and even a little more than 8% at constant currencies. Adjusted diluted earnings per share from continuing operations was $1.88. The consensus was $1.83 in adjusted EPS and $1.76 billion in revenue. Annual revenues were $6.94 billion for adjusted earnings per share of $6.89. For the 2023 financial year, the group envisages revenue growth of 1.5 to 3.5%, as well as an adjusted EPS ranging from $6.95 to $7.15.
©2023 Boursier.com